UPDATE : Wednesday, August 21, 2019
26 new drugs approved in H1
Twenty-six new pharmaceutical products received approval in Korea in the fi...
by Lee Hye-seon  |  2019-07-02 14:31
Korean, US national cancer centers co-research proteogenomics
The National Cancer Center (NCC) has signed a memorandum of understanding w...
by Lee Han-soo  |  2019-07-02 12:11
[News Focus]Yuhan pulled off $3.1 billion licensing deals in one year. How?
Yuhan Corp. recently made headlines by signing an $870 million licensing de...
by Jeong Sae-im  |  2019-07-02 12:11
Regulator OKs nation’s 1st clinical trial for ‘digital treatment’
The Ministry of Food and Drug Safety has approved Nunaps’ clinical trial of...
by Lee Han-soo  |  2019-07-01 16:35
[Special]Korean drugmakers harbor undue expectations on global blockbusters
“The pharmaceutical and biotech industry will lead our economy soon. Even n...
by Jeong Sae-im  |  2019-07-01 16:19
Huons launches new osteoarthritis treatment
Huons said that it has launched “Hi Hyal Once,” an osteoarthritis treatment...
by Lee Han-soo  |  2019-07-01 15:13
Eli Lilly Korea gains further reimbursement for psoriasis treatment Taltz
The Korean branch of Eli Lilly said that it had gained additional reimburse...
by Lee Han-soo  |  2019-07-01 14:27
BMS Korea files administrative suit to appeal Eliquis price cut
The price reduction of BMS Korea Pharmaceutical’s blood thinner Elidquis ha...
by Kim Yun-mi  |  2019-07-01 14:16
Multinationals face suspension of drug imports
The regulator ordered multinational pharmaceutical firms, including MSD Kor...
by Lee Hye-seon  |  2019-07-01 14:12
Yuhan signs $870 million licensing deal with Boehringer Ingelheim
Yuhan announced a joint development and licensing agreement with Boehringer...
by Lee Han-soo  |  2019-07-01 14:09
'Proteogenomics will improve ability to prevent, diagnose and treat cancer at molecular level'
With recent advancements in sequencing technologies, scientists are no long...
by Lee Han-soo  |  2019-06-28 17:43
Lilly anticipates Trulicity’s growth as GLP-1 receptor antagonists get popular
As physicians have increasingly recommended glucagon-like peptide-1 (GLP-1)...
by Kim Yun-mi  |  2019-06-28 16:12
BNO BIO to invest $1 million in Israeli biotech venture
BNO BIO, a joint venture between Bukwang Pharm and chemical and energy comp...
by Jeong Sae-im  |  2019-06-28 16:10
Government to help cover costs for injuries from side effects
The government said it would help patients get compensation for diseases ca...
by Lee Hye-seon  |  2019-06-28 12:30
SNUH finds clue for early diagnosis of undifferentiated thyroid cancer
Researchers at Seoul National University Hospital and Macrogen have discove...
by Lee Han-soo  |  2019-06-28 11:05
Shareholders in shock over HLB’s phase-3 trial setback
Investors in HLB have expressed shock after the KOSDAQ-listed firm announce...
by Jeong Sae-im  |  2019-06-28 10:47
Korea gives medical equipment to Uganda
The Korea Foundation of International Healthcare (KOFIH) said that it has d...
by Lee Han-soo  |  2019-06-27 17:48
Samsung Bioepis readies phase-3 trial on Soliris biosimilar
Samsung Bioepis is speeding up to develop a biosimilar of Soliris (eculizum...
by Lee Hye-seon  |  2019-06-27 17:14
Eutilex unveils immunotherapy development strategy
Eutilex presented its immunotherapy development strategy during the "Global...
by Lee Han-soo  |  2019-06-27 16:51
SNUH, Future Robot develop telementoring robot
Seoul National University Hospital and Future Robot, a local company develo...
by Lee Han-soo  |  2019-06-27 16:50
Back to Top